1、Bulletin 80A0108-01ENSMART MANUFACTURING AssessmentGuiding Pharmaceutical Manufacturers in the Digital Transformation Journey Towards Smart FactoryDemographic changesDevelopments in biotechnologyNew infectious disease threatsIncreased demand for pharmaceuticalsUniversalization of advanced pharmaceut

2、icalsAccelerating developmentEnvironmentIndustry KSFCost-optimized productionSIRI approach icon適正生産開発短縮New production(Response to new modalities)SIRI approach icon適正生産開発短縮Reduced development lead timeSIRI approach icon適正生産開発短縮The world is rapidly and continuously changing,and pharmaceutical manufact

3、urers face new issues everyday.The industry has a mission of achieving personal well-being while responding to an ever-changing environment to deliver safe and secure medicines to society,but it is becoming increasingly challenging.Demand for pharmaceuticals is steadily increasing as global populati

4、on grows and developed countries age.There is increasing pressure from the national governments to hold down drug prices and keep medical costs down in order to reduce the governments social security burden.At the same time,the industry must respond to stricter regulations and higher quality assuran

5、ce levels.In addition to conventional small molecules,a variety of new modalities,such as antibody drugs,nucleic acid and peptide drugs,and cell therapy,will be put into practical use at an accelerated pace.To be successful in this environment,companies must employ new technologies such as AI and IT

6、 to continuously drive business while navigating these known or sudden challenges.Future of Pharmaceutical manufacturersSMART MANUFACTURING Assessment2Accelerating DX in Pharmaceutical ManufacturingFor pharma manufacturers,meeting cost,productivity,and stable supply is essential,but at the same time